S&P 500   4,279.05 (-0.21%)
DOW   33,357.21 (-0.45%)
QQQ   360.59 (+0.65%)
AAPL   173.52 (+1.35%)
MSFT   318.30 (+0.81%)
META   305.71 (+1.83%)
GOOGL   133.65 (+2.13%)
AMZN   129.29 (+1.71%)
TSLA   250.03 (-0.08%)
NVDA   448.11 (+3.02%)
NIO   8.77 (-2.99%)
BABA   86.32 (-0.48%)
AMD   102.23 (-0.57%)
T   14.85 (-1.13%)
F   12.32 (-0.81%)
MU   67.77 (-0.38%)
CGC   0.79 (+0.51%)
GE   109.41 (-1.03%)
DIS   81.07 (+0.02%)
AMC   7.89 (-1.25%)
PFE   33.22 (+0.15%)
PYPL   58.79 (+0.56%)
NFLX   381.58 (+1.05%)
S&P 500   4,279.05 (-0.21%)
DOW   33,357.21 (-0.45%)
QQQ   360.59 (+0.65%)
AAPL   173.52 (+1.35%)
MSFT   318.30 (+0.81%)
META   305.71 (+1.83%)
GOOGL   133.65 (+2.13%)
AMZN   129.29 (+1.71%)
TSLA   250.03 (-0.08%)
NVDA   448.11 (+3.02%)
NIO   8.77 (-2.99%)
BABA   86.32 (-0.48%)
AMD   102.23 (-0.57%)
T   14.85 (-1.13%)
F   12.32 (-0.81%)
MU   67.77 (-0.38%)
CGC   0.79 (+0.51%)
GE   109.41 (-1.03%)
DIS   81.07 (+0.02%)
AMC   7.89 (-1.25%)
PFE   33.22 (+0.15%)
PYPL   58.79 (+0.56%)
NFLX   381.58 (+1.05%)
S&P 500   4,279.05 (-0.21%)
DOW   33,357.21 (-0.45%)
QQQ   360.59 (+0.65%)
AAPL   173.52 (+1.35%)
MSFT   318.30 (+0.81%)
META   305.71 (+1.83%)
GOOGL   133.65 (+2.13%)
AMZN   129.29 (+1.71%)
TSLA   250.03 (-0.08%)
NVDA   448.11 (+3.02%)
NIO   8.77 (-2.99%)
BABA   86.32 (-0.48%)
AMD   102.23 (-0.57%)
T   14.85 (-1.13%)
F   12.32 (-0.81%)
MU   67.77 (-0.38%)
CGC   0.79 (+0.51%)
GE   109.41 (-1.03%)
DIS   81.07 (+0.02%)
AMC   7.89 (-1.25%)
PFE   33.22 (+0.15%)
PYPL   58.79 (+0.56%)
NFLX   381.58 (+1.05%)
S&P 500   4,279.05 (-0.21%)
DOW   33,357.21 (-0.45%)
QQQ   360.59 (+0.65%)
AAPL   173.52 (+1.35%)
MSFT   318.30 (+0.81%)
META   305.71 (+1.83%)
GOOGL   133.65 (+2.13%)
AMZN   129.29 (+1.71%)
TSLA   250.03 (-0.08%)
NVDA   448.11 (+3.02%)
NIO   8.77 (-2.99%)
BABA   86.32 (-0.48%)
AMD   102.23 (-0.57%)
T   14.85 (-1.13%)
F   12.32 (-0.81%)
MU   67.77 (-0.38%)
CGC   0.79 (+0.51%)
GE   109.41 (-1.03%)
DIS   81.07 (+0.02%)
AMC   7.89 (-1.25%)
PFE   33.22 (+0.15%)
PYPL   58.79 (+0.56%)
NFLX   381.58 (+1.05%)
ETR:FME

Fresenius Medical Care AG & Co. KGaA (FME) Stock Forecast, Price & News

€40.84
-0.16 (-0.39%)
(As of 09/29/2023 ET)
Compare
Today's Range
€40.73
€41.81
50-Day Range
€39.70
€48.86
52-Week Range
€25.95
€49.62
Volume
544,011 shs
Average Volume
704,197 shs
Market Capitalization
$11.98 billion
P/E Ratio
20.12
Dividend Yield
2.74%
Price Target
€30.19

Fresenius Medical Care AG & Co. KGaA MarketRank™ Forecast

Analyst Rating
0.00 Rating Score
Upside/​Downside
26.1% Downside
€30.19 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.11
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.59 out of 5 stars


FME stock logo

About Fresenius Medical Care AG & Co. KGaA (ETR:FME) Stock

Fresenius Medical Care AG & Co. KGaA provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

FME Price History

FME Stock News Headlines

Nuclear Revival Creates Opportunities for Uranium
Uranium companies set to benefit from increased demand for clean energy.
Why Shares of Fresenius Medical Jumped This Week
Nuclear Revival Creates Opportunities for Uranium
Uranium companies set to benefit from increased demand for clean energy.
Fresenius Medical Care AG & Co. KGaA (FME.SG)
Fresenius takes tentative step on road to breakup
Fresenius Medical's (FMS) Q4 Earnings and Revenues Beat
Fresenius Names New CEO at Transfusion Business Kabi
See More Headlines
Receive FME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius Medical Care AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Medical Care Facilities
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
124,295
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
€30.19
High Stock Price Forecast
€46.83
Low Stock Price Forecast
€17.10
Forecasted Upside/Downside
-26.1%
Consensus Rating
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$595.63 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$19.62 billion
Cash Flow
€4.14 per share
Book Value
€46.11 per share

Miscellaneous

Free Float
N/A
Market Cap
$11.98 billion
Optionable
Not Optionable
Beta
0.98
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Ms. Helen Giza (Age 55)
    CEO, Acting CFO & Chair of Mgmt Board of Fresenius Med. Care Mgmt AG
    Comp: $3.21M
  • Dr. Franklin W. Maddux F.A.C.P. (Age 66)
    Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG
    Comp: $2.42M
  • Mr. William J. Valle (Age 63)
    Management Board Member for Care Delivery of Fresenius Medical Care Management AG
    Comp: $3.93M
  • Dr. Katarzyna Mazur-Hofsab Ph.D. (Age 60)
    Management Board Member for Care Enablement of Fresenius Medical Care Management AG
    Comp: $2.35M
  • Mr. Roberto Fuste (Age 71)
    Exec. Advisor for Regional Strategy
  • Dr. Dominik Heger
    Exec. VP and Head of Investor Relations, Strategic Devel. & Communications
  • Mr. Borries Von Muller (Age 62)
    Sr. VP of Global HR Employee Communications
  • Mr. Joachim Weith
    Sr. VP of Corp. Communications & Gov.al Affairs
  • Mr. Oliver Maier
    Sr. VP Investor Relations
  • Dr. Gail-Suzanne Brown
    Sr. VP of R&D













FME Stock - Frequently Asked Questions

What is Fresenius Medical Care AG & Co. KGaA's stock price forecast for 2023?

0 brokerages have issued 1-year price targets for Fresenius Medical Care AG & Co. KGaA's shares. Their FME share price forecasts range from €17.10 to €46.83. On average, they predict the company's stock price to reach €30.19 in the next twelve months. This suggests that the stock has a possible downside of 26.1%.
View analysts price targets for FME
or view top-rated stocks among Wall Street analysts.

How have FME shares performed in 2023?

Fresenius Medical Care AG & Co. KGaA's stock was trading at €30.57 at the start of the year. Since then, FME shares have increased by 33.6% and is now trading at €40.84.
View the best growth stocks for 2023 here
.

Is Fresenius Medical Care AG & Co. KGaA a good dividend stock?

Fresenius Medical Care AG & Co. KGaA (ETR:FME) pays an annual dividend of €1.12 per share and currently has a dividend yield of 2.74%. The dividend payout ratio is 55.17%. This payout ratio is at a healthy, sustainable level, below 75%.

What other stocks do shareholders of Fresenius Medical Care AG & Co. KGaA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius Medical Care AG & Co. KGaA investors own include Petra Diamonds (PDL), Fresenius Medical Care AG & Co. KGaA (FMS), RWE Aktiengesellschaft (RWE), Deutsche Lufthansa (LHA), Rio Tinto Group (RIO), Covestro (1COV), Carillion (CLLN), Nokia Oyj (NOK) and Oxford Biomedica (OXB).

What is Fresenius Medical Care AG & Co. KGaA's stock symbol?

Fresenius Medical Care AG & Co. KGaA trades on the ETR under the ticker symbol "FME."

What is Fresenius Medical Care AG & Co. KGaA's stock price today?

One share of FME stock can currently be purchased for approximately €40.84.

How much money does Fresenius Medical Care AG & Co. KGaA make?

Fresenius Medical Care AG & Co. KGaA (ETR:FME) has a market capitalization of $11.98 billion and generates $19.62 billion in revenue each year. The company earns $595.63 million in net income (profit) each year or €2.03 on an earnings per share basis.

How many employees does Fresenius Medical Care AG & Co. KGaA have?

The company employs 124,295 workers across the globe.

How can I contact Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA's mailing address is Else-Kroener-Strasse 1, BAD HOMBURG, 61352, Germany. The official website for the company is www.freseniusmedicalcare.com. The company can be reached via phone at +49-6172-6090.

This page (ETR:FME) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -